• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

哺乳动物心脏中的胰高血糖素及其受体。

Glucagon and Its Receptors in the Mammalian Heart.

机构信息

Institute for Pharmacology and Toxicology, Medical Faculty, Martin Luther University Halle-Wittenberg, Magdeburger Straße 4, D-06097 Halle (Saale), Germany.

Department of Cardiac Surgery, Mid-German Heart Center, University Hospital Halle, Ernst Grube Straße 40, D-06097 Halle (Saale), Germany.

出版信息

Int J Mol Sci. 2023 Aug 15;24(16):12829. doi: 10.3390/ijms241612829.

DOI:10.3390/ijms241612829
PMID:37629010
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10454195/
Abstract

Glucagon exerts effects on the mammalian heart. These effects include alterations in the force of contraction, beating rate, and changes in the cardiac conduction system axis. The cardiac effects of glucagon vary according to species, region, age, and concomitant disease. Depending on the species and region studied, the contractile effects of glucagon can be robust, modest, or even absent. Glucagon is detected in the mammalian heart and might act with an autocrine or paracrine effect on the cardiac glucagon receptors. The glucagon levels in the blood and glucagon receptor levels in the heart can change with disease or simultaneous drug application. Glucagon might signal via the glucagon receptors but, albeit less potently, glucagon might also signal via glucagon-like-peptide-1-receptors (GLP1-receptors). Glucagon receptors signal in a species- and region-dependent fashion. Small molecules or antibodies act as antagonists to glucagon receptors, which may become an additional treatment option for diabetes mellitus. Hence, a novel review of the role of glucagon and the glucagon receptors in the mammalian heart, with an eye on the mouse and human heart, appears relevant. Mouse hearts are addressed here because they can be easily genetically modified to generate mice that may serve as models for better studying the human glucagon receptor.

摘要

胰高血糖素对哺乳动物心脏发挥作用。这些作用包括收缩力、跳动频率的改变以及心脏传导系统轴的变化。胰高血糖素对心脏的影响因物种、区域、年龄和伴随疾病而异。根据所研究的物种和区域,胰高血糖素的收缩作用可能很强、适度或甚至不存在。哺乳动物心脏中可检测到胰高血糖素,它可能通过自分泌或旁分泌作用作用于心脏胰高血糖素受体。血液中的胰高血糖素水平和心脏中的胰高血糖素受体水平可能因疾病或同时应用药物而改变。胰高血糖素可能通过胰高血糖素受体发出信号,但尽管作用较弱,胰高血糖素也可能通过胰高血糖素样肽-1 受体 (GLP1 受体) 发出信号。胰高血糖素受体以依赖于物种和区域的方式发出信号。小分子或抗体可作为胰高血糖素受体的拮抗剂,这可能成为治疗糖尿病的另一种选择。因此,对哺乳动物心脏中胰高血糖素和胰高血糖素受体的作用进行新的综述,关注小鼠和人心显得很有必要。本文关注小鼠心脏,因为它们可以很容易地通过基因修饰产生可能有助于更好地研究人类胰高血糖素受体的小鼠模型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56ec/10454195/38c90742b20c/ijms-24-12829-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56ec/10454195/38c90742b20c/ijms-24-12829-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56ec/10454195/38c90742b20c/ijms-24-12829-g001.jpg

相似文献

1
Glucagon and Its Receptors in the Mammalian Heart.哺乳动物心脏中的胰高血糖素及其受体。
Int J Mol Sci. 2023 Aug 15;24(16):12829. doi: 10.3390/ijms241612829.
2
Role of Dopamine in the Heart in Health and Disease.多巴胺在心脏健康和疾病中的作用。
Int J Mol Sci. 2023 Mar 6;24(5):5042. doi: 10.3390/ijms24055042.
3
Function and Role of Histamine H Receptor in the Mammalian Heart.组胺H受体在哺乳动物心脏中的功能与作用
Pharmaceuticals (Basel). 2023 May 11;16(5):734. doi: 10.3390/ph16050734.
4
Robust anti-obesity and metabolic effects of a dual GLP-1/glucagon receptor peptide agonist in rodents and non-human primates.一种双重GLP-1/胰高血糖素受体肽激动剂在啮齿动物和非人类灵长类动物中具有强大的抗肥胖和代谢作用。
Diabetes Obes Metab. 2016 Dec;18(12):1176-1190. doi: 10.1111/dom.12735. Epub 2016 Aug 15.
5
Receptor identification and physiological characterisation of glucagon-like peptide-2 in the rat heart.大鼠心脏胰高血糖素样肽-2 受体的鉴定和生理学特性。
Nutr Metab Cardiovasc Dis. 2012 Jun;22(6):486-94. doi: 10.1016/j.numecd.2010.07.014. Epub 2010 Dec 24.
6
Evidence for a lack of inotropic and chronotropic effects of glucagon and glucagon receptors in the human heart.没有证据表明胰高血糖素及其受体对人心力和心率有正性变力和变时作用。
Cardiovasc Diabetol. 2023 May 30;22(1):128. doi: 10.1186/s12933-023-01859-8.
7
Glucagon and Glucagon-like Peptide-1 Receptors: Promising Therapeutic Targets for an Effective Management of Diabetes Mellitus.胰高血糖素和胰高血糖素样肽-1 受体:糖尿病治疗管理的有效新靶点。
Curr Pharm Des. 2020;26(4):501-508. doi: 10.2174/1381612826666200131143231.
8
Effects of the once-weekly glucagon-like peptide-1 receptor agonist dulaglutide on ambulatory blood pressure and heart rate in patients with type 2 diabetes mellitus.每周一次的胰高血糖素样肽-1受体激动剂度拉糖肽对2型糖尿病患者动态血压和心率的影响。
Hypertension. 2014 Oct;64(4):731-7. doi: 10.1161/HYPERTENSIONAHA.114.03062. Epub 2014 Jun 30.
9
Responsiveness to glucagon in fetal hearts. Species variability and apparent disparities between changes in beating, adenylate cyclase activation, and cyclic AMP concentration.胎儿心脏对胰高血糖素的反应性。物种差异以及心跳变化、腺苷酸环化酶激活和环磷酸腺苷浓度变化之间明显的差异。
J Clin Invest. 1976 Mar;57(3):551-8. doi: 10.1172/JCI108310.
10
Oxyntomodulin increases intrinsic heart rate in mice independent of the glucagon-like peptide-1 receptor.胃泌酸调节素可增加小鼠的固有心率,且不依赖于胰高血糖素样肽-1受体。
Am J Physiol Regul Integr Comp Physiol. 2007 Feb;292(2):R962-70. doi: 10.1152/ajpregu.00405.2006. Epub 2006 Oct 12.

引用本文的文献

1
Glucagon in metabolic disease: a mini-review of emerging multi-organ roles beyond glycemic control.胰高血糖素在代谢性疾病中的作用:对血糖控制以外新兴多器官作用的简要综述
Front Endocrinol (Lausanne). 2025 Jul 31;16:1645041. doi: 10.3389/fendo.2025.1645041. eCollection 2025.
2
Exenatide and glucagon co-infusion increases myocardial glucose uptake and improves markers of diastolic dysfunction in adults with type 2 diabetes.艾塞那肽与胰高血糖素联合输注可增加2型糖尿病成人患者的心肌葡萄糖摄取,并改善舒张功能障碍标志物。
Sci Rep. 2025 Jul 1;15(1):21404. doi: 10.1038/s41598-025-04559-3.
3
Cardiac neurons expressing a glucagon-like receptor mediate cardiac arrhythmia induced by high-fat diet in .

本文引用的文献

1
Evidence for a lack of inotropic and chronotropic effects of glucagon and glucagon receptors in the human heart.没有证据表明胰高血糖素及其受体对人心力和心率有正性变力和变时作用。
Cardiovasc Diabetol. 2023 May 30;22(1):128. doi: 10.1186/s12933-023-01859-8.
2
The ubiquitination status of the glucagon receptor determines signal bias.胰高血糖素受体的泛素化状态决定了信号偏向。
J Biol Chem. 2023 May;299(5):104690. doi: 10.1016/j.jbc.2023.104690. Epub 2023 Apr 8.
3
Negative allosteric modulation of the glucagon receptor by RAMP2.RAMP2 对胰高血糖素受体的负变构调节。
表达胰高血糖素样受体的心脏神经元介导高脂饮食诱导的心律失常。
bioRxiv. 2025 Mar 12:2023.12.13.571403. doi: 10.1101/2023.12.13.571403.
4
Advances in Insulin Resistance-Molecular Mechanisms, Therapeutic Targets, and Future Directions.胰岛素抵抗的进展——分子机制、治疗靶点及未来方向
Int J Mol Sci. 2025 Mar 13;26(6):2574. doi: 10.3390/ijms26062574.
5
A once-daily GLP-1/GIP/glucagon receptor tri-agonist (NN1706) lowers body weight in rodents, monkeys and humans.一种每日一次的胰高血糖素样肽-1/葡萄糖依赖性促胰岛素多肽/胰高血糖素受体三联激动剂(NN1706)可降低啮齿动物、猴子和人类的体重。
Mol Metab. 2025 Jun;96:102129. doi: 10.1016/j.molmet.2025.102129. Epub 2025 Mar 24.
6
Ubrogepant, erenumab, and eptinezumab antagonize positive inotropic effects of the calcitonin gene-related peptide in the isolated human atrium.ubrogepant、erenumab和eptinezumab可拮抗降钙素基因相关肽对离体人心房的正性肌力作用。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Mar 14. doi: 10.1007/s00210-025-04029-7.
7
Glucagon Can Increase Force of Contraction via Glucagon Receptors in the Isolated Human Atrium.胰高血糖素可通过分离的人心房中的胰高血糖素受体增加收缩力。
Int J Mol Sci. 2025 Jan 15;26(2):698. doi: 10.3390/ijms26020698.
8
Evaluating sex-specific responses to western diet across the lifespan: impact on cardiac function and transcriptomic signatures in C57BL/6J mice at 530 and 640/750 days of age.评估不同性别在整个生命周期对西式饮食的反应:对530日龄和640/750日龄C57BL/6J小鼠心脏功能和转录组特征的影响。
Cardiovasc Diabetol. 2024 Dec 28;23(1):454. doi: 10.1186/s12933-024-02565-9.
9
Bisphenol C Induces Cardiac Developmental Defects by Disrupting mA Homeostasis.双酚 C 通过破坏 mA 平衡引起心脏发育缺陷。
Environ Sci Technol. 2024 Oct 1;58(39):17259-17269. doi: 10.1021/acs.est.4c04373. Epub 2024 Aug 29.
10
GLP-1 receptor agonist-based therapies and cardiovascular risk: a review of mechanisms.基于 GLP-1 受体激动剂的治疗与心血管风险:机制综述。
J Endocrinol. 2024 Sep 19;263(1). doi: 10.1530/JOE-24-0046. Print 2024 Oct 1.
Cell. 2023 Mar 30;186(7):1465-1477.e18. doi: 10.1016/j.cell.2023.02.028.
4
Glucagon and exenatide improve contractile recovery following ischaemia/reperfusion in the isolated perfused rat heart.胰高血糖素和 exenatide 可改善离体灌注大鼠心脏缺血/再灌注后的收缩功能恢复。
Physiol Rep. 2023 Mar;11(6):e15597. doi: 10.14814/phy2.15597.
5
Cardiac Roles of Serotonin (5-HT) and 5-HT-Receptors in Health and Disease.血清素(5-HT)和 5-HT 受体在健康和疾病中的心脏作用。
Int J Mol Sci. 2023 Mar 1;24(5):4765. doi: 10.3390/ijms24054765.
6
High glucose-induced glucagon resistance and membrane distribution of GCGR revealed by super-resolution imaging.超分辨率成像揭示高糖诱导的胰高血糖素抵抗和胰高血糖素受体的膜分布
iScience. 2023 Jan 13;26(2):105967. doi: 10.1016/j.isci.2023.105967. eCollection 2023 Feb 17.
7
Neprilysin Inhibitors in Heart Failure: The Science, Mechanism of Action, Clinical Studies, and Unanswered Questions.心力衰竭中的中性肽链内切酶抑制剂:科学、作用机制、临床研究及未解决的问题
JACC Basic Transl Sci. 2022 Sep 7;8(1):88-105. doi: 10.1016/j.jacbts.2022.05.010. eCollection 2023 Jan.
8
Translational aspects of glucagon: current use and future prospects.胰高血糖素的转化研究:当前应用与未来前景
J Endocrinol. 2023 Mar 16;257(1). doi: 10.1530/JOE-22-0278. Print 2023 Apr 1.
9
Association of glucagon-like peptide-1 receptor agonists with cardiac arrhythmias in patients with type 2 diabetes or obesity: a systematic review and meta-analysis of randomized controlled trials.2型糖尿病或肥胖患者中胰高血糖素样肽-1受体激动剂与心律失常的关联:一项随机对照试验的系统评价和荟萃分析
Diabetol Metab Syndr. 2022 Dec 26;14(1):195. doi: 10.1186/s13098-022-00970-2.
10
Cardiovascular and Adverse Effects of Glucagon for the Management of Suspected Beta Blocker Toxicity: a Case Series.心血管和不良反应的胰高血糖素对管理疑似β阻滞剂毒性:一个案例系列。
J Med Toxicol. 2023 Jan;19(1):9-15. doi: 10.1007/s13181-022-00919-x. Epub 2022 Dec 7.